Method for producing red blood cells
View Patent ↗The invention relates to a method for the expansion and differentiation of haematopoietic stem cells into enucleated erythrocytes, in two steps: a first step in a culture medium, where cell proliferation and erythmid differentiation are induced in the presence of growth factors, and a second step modeling a reconstitution of the microenvironment, substantially without erythropoietin (EPO). Optionally, the method of culture may comprise an intermediate step, with haematopoietic growth factors.
1. An in vitro method for producing enucleated erythrocytes, said method comprising the steps of:
a) culturing for 6 to 11 days CD34+ haematopoietic stem cells in a culture medium that comprises stem cell factor (SCF), interleukin-3 (IL3), and erythropoietin (EPO);
b) culturing for 3 to 5 days the cells obtained in step a), in a culture medium that comprises at least EPO and is in contact with supporting cells, wherein the supporting cells are MS-5 stromal cells or mesenchymal stromal cells; and
c) culturing for 2 to 14 days the cells obtained in step b), while maintaining contact with said supporting cells, in the absence of any haematopoietic growth factor until red blood cells selected from the group consisting of reticulocytes, mature red blood cells, and combinations thereof are obtained.
2. The method of claim 1 , wherein the supporting cells are genetically modified cells.
3. The method of claim 1 , wherein the haematopoietic stem cells cultured in step a) are genetically modified cells.
4. The method of claim 3 , wherein the cells are capable of expressing an exogenous nucleotide sequence of interest.
5. The method of claim 4 , wherein the sequence of interest encodes a haemoglobin type.
6. The method of claim 1 , wherein step c) is performed until reticulocytes are obtained.
7. The method of claim 1 , wherein step c) is performed until mature red blood cells are obtained.
8. The method of claim 1 , wherein
a) the culturing of CD34+ haematopoietic stem cells is performed in a culture medium that comprises SCF, IL-3, and EPO for 8 days;
b) the culturing of the cells obtained in step a) is performed in a culture medium that comprises EPO, and is in contact with MS-5 stromal cells or mesenchymal stromal cells, for 3 days; and
c) the culturing of the cells obtained in step b), are maintained in contact with the MS-5 stromal cells or mesenchymal stromal cells, in the absence of any haematopoietic growth factor, for 4 days, whereby reticulocytes are obtained, or for 7 days, whereby mature red blood cells are obtained.
9. The method of claim 1 , wherein step c) is performed until a mixture of reticulocytes and mature red blood cells are obtained.
10. The method of claim 1 , wherein the CD34+ haematopoietic stem cells cultured in step a) are CD34+ cord blood cells.
11. The method of claim 1 , wherein the CD34+ haematopoietic stem cells cultured in step a) are obtained by leukapheresis.